Avenue Therapeutics, Inc. Quarterly report pursuant to Section 13 or 15(d)

Note 7 - Stockholders' Equity- Stock Warrants (Details) - USD ($)	3 Months Ended		12 Months Ended
	Jun. 30, 2024	Mar. 31, 2024	Dec. 31, 2023
Warrants, outstanding (in shares)	745,139	524,601
Outstanding, weighted average exercise price (in dollars per share)	$ 29.5	$ 32.42
Outstanding, December 31, 2023	$ 0	$ 0	$ 0
Warrants, Granted (in shares)	1,420,741	441,076
Warrants granted, weighted average exercise price (in dollars per share)	$ 6.25	$ 6.2
Warrants, Exercised (in shares)	(689,680)	(220,538)
Exercised, weighted average exercise price (in dollars per share)	$ 6.2	$ 22.55
Warrants, outstanding (in shares)	1,476,200	745,139	524,601
Outstanding, weighted average exercise price (in dollars per share)	$ 8.64	$ 29.5	$ 32.42